[Hypertension in type II diabetes mellitus]

Area of Science:

• Cardiology
• Endocrinology
• Pharmacology

Context:

• Hypertension management in patients with non-insulin-dependent diabetes mellitus (NIDDM) presents unique challenges.
• Comorbidities like coronary artery disease, myocardial infarction, and diabetic complications (nephropathy, neuropathy) must be considered.
• Antihypertensive therapies must not exacerbate insulin resistance or impair insulin secretion.

Purpose:

• To outline a strategic approach for antihypertensive treatment in NIDDM patients.
• To emphasize the importance of selecting drugs that do not adversely affect glycemic control or cardiovascular risk factors.
• To provide a stepwise treatment algorithm considering patient-specific complications.

Summary:

• Initial antihypertensive therapy should prioritize angiotensin converting enzyme inhibitors, potentially combined with calcium channel blockers.
• If blood pressure remains uncontrolled, alpha-adrenergic blockers, vasodilating agents, or sympatholytics can be added.
• Diuretics and beta-adrenergic blockers are indicated when insulin therapy is initiated or for specific conditions like nephropathy, heart failure, or arrhythmias.

Impact:

• This approach aims to optimize blood pressure control while minimizing risks associated with diabetes and cardiovascular disease.
• It guides clinicians in selecting antihypertensive medications that are safe and effective for diabetic patients.
• Facilitates better management of coexisting conditions in NIDDM patients, potentially reducing long-term complications.